ALDURAZYME از شرکت BIOMARIN

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

Biologic License Application (BLA): 125058

Company: BIOMARIN

Products on BLA 125058

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ALDURAZYME	LARONIDASE	2.9MG/ML	VIAL	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for BLA 125058

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/30/2003	ORIG-1	Approval		N/A; Orphan	Label (PDF) Letter Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/larobio043003LB.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/larobio043003L.htm https://web.archive.org/web/20170118085125/https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm080438.htm

Action Date

Submission

Action Type

Submission Classification

Review Priority; Orphan Status

Letters, Reviews, Labels, Patient Package Insert

Notes

Url

04/30/2003

ORIG-1

Approval

N/A; Orphan

Label (PDF)

Letter

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/larobio043003LB.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/larobio043003L.htm
https://web.archive.org/web/20170118085125/https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm080438.htm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/04/2019	SUPPL-244	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125058s244lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125058Orig1s244ltr.pdf
04/03/2013	SUPPL-220	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125058s220lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/125058Orig1s220ltr.pdf
07/13/2011	SUPPL-209	Supplement		Label is not available on this site.
05/14/2010	SUPPL-186	Supplement	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125058s0186lbl.pdf
05/20/2009	SUPPL-161	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125058s160, 125058s161lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/125058s0160,125058s0161ltr.pdf
05/20/2009	SUPPL-160	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125058s160, 125058s161lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/125058s0160,125058s0161ltr.pdf
08/25/2009	SUPPL-158	Supplement		Label is not available on this site.
04/14/2008	SUPPL-154	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/125058s154ltr.pdf

Labels for BLA 125058

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Url
12/04/2019	SUPPL-244	Labeling-Package Insert	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125058s244lbl.pdf
04/03/2013	SUPPL-220	Labeling	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125058s220lbl.pdf
05/14/2010	SUPPL-186	Labeling	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125058s0186lbl.pdf
05/20/2009	SUPPL-161	Efficacy	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125058s160, 125058s161lbl.pdf
05/20/2009	SUPPL-160	Efficacy	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125058s160, 125058s161lbl.pdf
04/30/2003	ORIG-1	Approval	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/larobio043003LB.pdf

حتما بخوانید : ALDOMET از شرکت MERCK

منبع : www.accessdata.fda.gov

ALDURAZYME از شرکت BIOMARIN